1 Treating COVID

765 bookmarks
Custom sorting
“THESE PATIENTS DESERVE TO BE HEARD” -VAERS WHISTLEBLOWER The HighWire
“THESE PATIENTS DESERVE TO BE HEARD” -VAERS WHISTLEBLOWER The HighWire
“THESE PATIENTS DESERVE TO BE HEARD” -VAERS WHISTLEBLOWER In a Highwire exclusive, Deborah Conrad, a hospitalist physician’s assistant on the frontlines of the pandemic, pulls back the curtain on the complete lack and disregard in her hospital for reporting Covid vaccine injury to VAERS, this country’s only mechanism to track the safety of these rushed-to-market, […]
·thehighwire.com·
“THESE PATIENTS DESERVE TO BE HEARD” -VAERS WHISTLEBLOWER The HighWire
! 1 Dr Peter McCullough lecture on the State of COVID treatment.
! 1 Dr Peter McCullough lecture on the State of COVID treatment.
Dr McCullough is a world renowned authority on COVID and editor-in-chief of two major medical journals. He discusses how most deaths are due to CDC refusing to permit pre-hospital treatment, which wou
·rumble.com·
! 1 Dr Peter McCullough lecture on the State of COVID treatment.
15 studies that indicate natural immunity from prior infection is more robust than the COVID vaccines - TheBlaze
15 studies that indicate natural immunity from prior infection is more robust than the COVID vaccines - TheBlaze
It's the 800-pound gorilla in the pandemic. The debate over forced vaccination with an ever-waning vaccine is cresting right around the time when the debate should be moot for a lot of people. Among the most fraudulent messages of the CDC's campaign of deceit is to force the vaccine on those with pr...
·theblaze.com·
15 studies that indicate natural immunity from prior infection is more robust than the COVID vaccines - TheBlaze
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity reinfections versus breakthrough infections medRxiv
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity reinfections versus breakthrough infections medRxiv
Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear. Methods We conducted a retrospective observational study comparing three groups: (1)SARS-CoV-2-naïve individuals who received a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine, (2)previously infected individuals who have not been vaccinated, and (3)previously infected and single dose vaccinated individuals. Three multivariate logistic regression models were applied. In all models we evaluated four outcomes: SARS-CoV-2 infection, symptomatic disease, COVID-19-related hospitalization and death. The follow-up period of June 1 to August 14, 2021, when the Delta variant was dominant in Israel. Results SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant ( P
·medrxiv.org·
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity reinfections versus breakthrough infections medRxiv
Dr. Warns FDA 46-Fold Increase in Vaccine Deaths reported thus far
Dr. Warns FDA 46-Fold Increase in Vaccine Deaths reported thus far
Sayer Ji gives an important update on concerning signals coming from government databases (including the WHO's VigiBase resource) that the Covid-19 vaccines are causing unprecedented levels of adverse events and deaths -- none of which are being reported on within the mainstream media.
·greenmedinfo.com·
Dr. Warns FDA 46-Fold Increase in Vaccine Deaths reported thus far
Ivermectin for Prevention and Treatment of COVID-19 Infection A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines - PMC
Ivermectin for Prevention and Treatment of COVID-19 Infection A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines - PMC
Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.We assessed the efficacy of ivermectin treatment in reducing ...
·ncbi.nlm.nih.gov·
Ivermectin for Prevention and Treatment of COVID-19 Infection A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines - PMC
Study Fully Vaccinated Healthcare Workers Carry 251 Times Viral
Study Fully Vaccinated Healthcare Workers Carry 251 Times Viral
A preprint paper by the prestigious Oxford University Clinical Research Group, published Aug. 10 in The Lancet, found vaccinated individuals carry 251 times the load of COVID-19 viruses in their nostrils compared to the unvaccinated
·greenmedinfo.com·
Study Fully Vaccinated Healthcare Workers Carry 251 Times Viral
13,000 Deaths, Nearly 600,000 Adverse Events Reported After COVID
13,000 Deaths, Nearly 600,000 Adverse Events Reported After COVID
VAERS data released Friday by the CDC showed a total of 595,622 reports of adverse events from all age groups following COVID vaccines, including 13,068 deaths and 81,050 serious injuries between Dec. 14, 2020 and Aug. 13, 2021
·greenmedinfo.com·
13,000 Deaths, Nearly 600,000 Adverse Events Reported After COVID